Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)
- Resource Type
- Article
- Authors
- Yang, Yunpeng; Pan, Jianji; Wang, Hui; Zhao, Yuanyuan; Qu, Shenhong; Chen, Nianyong; Chen, Xiaozhong; Sun, Yan; He, Xiaohui; Hu, Chaosu; Lin, Lizhu; Yu, Qitao; Wang, Siyang; Wang, Guihua; Lei, Feng; Wen, Jiyu; Yang, Kunyu; Lin, Zhixiong; Guo, Ye; Chen, Shaoqing; Huang, Xiaoming; Wu, Yanjie; Liang, Liang; Chen, Chenqi; Bai, Fan; Ma, Xiaopeng; Zhang, Yun; Leaw, Shiangjiin; Zhang, Li; Fang, Wenfeng
- Source
- In Cancer Cell 12 June 2023 41(6):1061-1072
- Subject
- Language
- ISSN
- 1535-6108